Orion Biotechnology Reports Positive Results for Colorectal Cancer in Preclinical Study
15 janv. 2019 09h00 HE
|
Orion Biotechnology Canada Ltd
OTTAWA, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced preclinical data produced in collaboration with Charles River...
Orion Biotechnology acquires patent portfolio for potent CCR5 chemokine antagonist
06 sept. 2018 13h08 HE
|
Orion Biotechnology Canada Ltd
OTTAWA, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced that its subsidiary, Orion Biotechnology Switzerland Sàrl, has...